Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2

NCT00015041 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Opioid-Related Disorders
Substance-Related Disorders

Interventions

DRUG: Buprenorphine

Sponsor

National Institute on Drug Abuse (NIDA)

Collaborators

[object Object]